Empagliflozin 10 mg
HS-2017-01
Phase 3 small_molecule completed
Quick answer
Empagliflozin 10 mg for Acute Myocardial Infarction is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Acute Myocardial Infarction
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed